Extinction of conditioned opiate withdrawal in rats is blocked by intracerebroventricular infusion of an NMDA receptor antagonist

Neuroscience Letters

Volumn 541, Issue , 2013, Pages 39-42

  Coleman, Brian R ^a,b   Carlezon Jr , William A ^a,b   Myers, Karyn M ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Addiction; Extinction; Glutamate; Morphine; NMDA receptor; Withdrawal

Indexed keywords

D,L 2 AMINO 5 PHOSPHOVALERIC ACID; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALOXONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVERSION; CONDITIONED REFLEX; CONDITIONING; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG WITHDRAWAL; FEAR; GROUP DYNAMICS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; TASK PERFORMANCE;

2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; AVOIDANCE LEARNING; CONDITIONING, CLASSICAL; EXTINCTION, PSYCHOLOGICAL; INFUSIONS, INTRAVENTRICULAR; MALE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84876412249     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.01.049     Document Type: Article

References (17)

1. Botreau F., Paolone G., Stewart J. d-Cycloserine facilitates extinction of a cocaine-induced conditioned place preference. Behav. Brain Res. 2006, 172:173-178.
2. Carlezon W.A., Wise R.A. Microinjections of phencyclidine (PCP) and related drugs into nucleus accumbens shell potentiate medial forebrain bundle brain stimulation reward. Psychopharmacology (Berl) 1996, 128:413-420.
3. Conklin C.A., Tiffany S.T. Applying extinction research and theory to cue-exposure addiction treatments. Addiction 2002, 97:155-167.
4. Davis M. NMDA receptors and fear extinction: implications for cognitive behavioral therapy. Dialogues Clin. Neurosci. 2011, 13:463-474.
5. Feltenstein M.W., See R.E. NMDA receptor blockade in the basolateral amygdala disrupts consolidation of stimulus-reward memory and extinction learning during reinstatement of cocaine-seeking in an animal model of relapse. Neurobiol. Learn. Mem. 2007, 88:435-444.
6. Gold L.H., Stinus L., Inturrisi C.E., Koob G.F. Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat. Eur. J. Pharmacol. 1994, 21:45-51.
7. Hsu E., Packard M.G. Medial prefrontal cortex infusions of bupivacaine or AP-5 block extinction of amphetamine conditioned place preference. Neurobiol. Learn. Mem. 2008, 89:504-512.
8. Myers K.M., Carlezon W.A. d-cycloserine facilitates extinction of naloxone-induced conditioned place aversion in morphine-dependent rats. Biol. Psychiatry 2010, 67:85-87.
9. Myers K.M., Carlezon W.A. d-cycloserine effects on extinction of conditioned responses to drug-related cues. Biol. Psychiatry 2012, 71:947-955.
10. Myers K.M., Carlezon W.A., Davis M. Glutamate receptors in extinction and extinction-based therapies for psychiatric illness. Neuropsychopharmacology 2011, 36:274-293.
11. Myers K.M., Bechtholt-Gompf A.J., Coleman B.R., Carlezon W.A. Extinction of conditioned opiate withdrawal in rats in a two-chambered place conditioning apparatus. Nat. Protoc. 2012, 7:517-526.
12. Norberg M.M., Krystal J.H., Tolin D.F. A meta-analysis of d-cycloserine and the facilitation of fear extinction and exposure therapy. Biol. Psychiatry 2008, 63:1118-1126.
13. Pavlov I.P. Conditioned Reflexes: An Investigation of the Physiological Activity of the Cerebral Cortex 1927, Oxford University Press, London.
14. Rothbaum B.O., Hodges L.F. The use of virtual reality exposure in the treatment of anxiety disorders. Behav. Modif. 1999, 23:507-525.
15. Stinus L., Caille S., Koob G.F. Opiate withdrawal-induced place aversion lasts for up to 16 weeks. Psychopharmacology (Berl) 2000, 149:115-120.
16. Taylor J.R., Olausson P., Quinn J.J., Torregrossa M.M. Targeting extinction and reconsolidation mechanisms to combat the impact of drug cues on addiction. Neuropharmacology 2009, 56(Suppl. 1):186-195.
17. Weiss F. Neurobiology of craving, conditioned reward and relapse. Curr. Opin. Pharmacol. 2005, 5:9-19.